Floatz logo

Therapeutic Asset Ratings

2,394 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Turoctocog Alfa
Congenital Bleeding Disorder
Novo Nordisk A/SP4A (85)
Turoctocog Alfa
Haemophilia A
Novo Nordisk A/SP4A (85)
GLY-GLY-GLY-CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (4-9 DISULFIDE)
Hepatorenal Syndrome
Noorik Biopharmaceuticals AGP4A (84)
Recombinant Alpha-Galactosidase A
Fabry Disease
ShireP4A (84)
Agalsidase Beta
Fabry Disease
SanofiP4A (83)
Velaglucerase Alfa
Gaucher Disease
TakedaP4A (83)
Avalglucosidase Alfa
Glycogen Storage Disease Type II
Genzyme, a Sanofi CompanyP4A (82)
.ALPHA.-1 PROTEASE INHIBITOR
Alpha 1-Antitrypsin Deficiency
Grifols Therapeutics LLCP4A (81)
PHENYLASE
Phenylketonuria (PKU)
BioMarin PharmaceuticalP4A (81)
Semaglutide
Metabolism and Nutrition Disorder
Nordsjaellands HospitalP4A (81)
Setmelanotide
Bardet Biedl Syndrome (BBS)
Tom HühneP4A (81)
Alglucosidase Alfa
Pompe Disease
Erasmus Medical CenterP4A (80)
Avalglucosidase Alfa
Pompe Disease
Genzyme, a Sanofi CompanyP4A (80)
Rasburicase
Tumor Lysis Syndrome
M.D. Anderson Cancer CenterP4A (80)
Nonacog Beta Pegol
Haemophilia B
Novo Nordisk A/SP3A (80)
Pegunigalsidase Alfa
Fabry Disease
Chiesi ItaliaP3A (80)
Glatiramer
Relapsing Remitting Multiple Sclerosis
University Hospital, MontpellierP4BBB (79)
Liraglutide
PCOS
Peking University Third HospitalP4BBB (79)
Liraglutide
Type 1 Diabetes
Dasman Diabetes InstituteP4BBB (79)
Liraglutide
Type 2 Diabetes Mellitus
RenJi HospitalP4BBB (79)
Rurioctocog Alfa Pegol
Hemophilia A
TakedaP4BBB (79)
Semaglutide
Diabetes Mellitus, Type 2
Shanghai Jiao Tong University School of MedicineP4BBB (79)
Semaglutide
PCOS
Methodist Health SystemP4BBB (79)
Alglucosidase Alfa
Pompe Disease (Late-onset)
Erasmus Medical CenterP4BBB (78)
ASPARAGINASE
Adult Acute Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP4BBB (78)
Showing 1 to 25 of 2,394 assets
PreviousPage 1 of 96Next